Submission Details
| 510(k) Number | K220558 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 28, 2022 |
| Decision Date | November 17, 2022 |
| Days to Decision | 262 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
K220558 is an FDA 510(k) clearance for the Blood Administration Sets, a Set, Blood Transfusion (Class II — Special Controls, product code BRZ), submitted by Baxter Healthcare Corporation (Round Lake, US). The FDA issued a Cleared decision on November 17, 2022, 262 days after receiving the submission on February 28, 2022. This device falls under the General Hospital review panel. Regulated under 21 CFR 880.5440.
| 510(k) Number | K220558 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 28, 2022 |
| Decision Date | November 17, 2022 |
| Days to Decision | 262 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
| Product Code | BRZ — Set, Blood Transfusion |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 880.5440 |